Deciphering an isolated lung phenotype of NKX2-1 frameshift pathogenic variant

Background to perform a functional analysis of a new NK2 homeobox 1 (NKX2-1) variant (c.85_86del denominated NKX2-1DEL) identified in a family presenting with isolated respiratory disease, in comparison to another frameshift variant (c.254dup denominated NKX2-1DUP) identified in a subject with classical brain-lung-thyroid syndrome. Methods pathogenic variants were introduced into the pcDNA3-1(+)-wt-TTF1 plasmid. The proteins obtained were analyzed by western blot assay. Subcellular localization was assessed by confocal microscopy in A549 and Nthy cells. Transactivation of SFTPA, SFTPB, SFTPC, and ABCA3 promoters was assessed in A549 cells. Thyroglobulin promoter activity was measured with the paired box gene 8 (PAX8) cofactor in Nthy cells. Results The two sequence variants were predicted to produce aberrant proteins identical from the 86th amino acid, with deletion of their functional homeodomain, including the nuclear localization signal. However, 3D conformation prediction of the conformation prediction of the mutant protein assumed the presence of a nuclear localization signal, a bipartite sequence, confirmed by confocal microscopy showing both mutant proteins localized in the nucleus and cytoplasm. Transcriptional activity with SFTPA, SFTPB, SFTPC, ABCA3 and thyroglobulin promoters was significantly decreased with both variants. However, with NKX2-1DEL, thyroglobulin transcriptional activity was maintained with the addition of PAX8. Conclusion These results provide novel insights into understanding the molecular mechanism of phenotypes associated with NKX2-1 pathogenic variants.

[1]  OUP accepted manuscript , 2022, Nucleic Acids Research.

[2]  M. Yaffe,et al.  TAZ/WWTR1 Mediates the Pulmonary Effects of NKX2-1 Mutations in Brain-Lung-Thyroid Syndrome , 2018, The Journal of clinical endocrinology and metabolism.

[3]  T. Todros,et al.  Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature. , 2018, Minerva ginecologica.

[4]  R. Epaud,et al.  Heterogeneity of lung disease associated with NK2 homeobox 1 mutations. , 2017, Respiratory medicine.

[5]  S. Simon,et al.  Deciphering the mechanism of Q145H SFTPC mutation unmasks a splicing defect and explains the severity of the phenotype , 2017, European Journal of Human Genetics.

[6]  A. Munnich,et al.  Mutations in BOREALIN cause thyroid dysgenesis , 2016, Human Molecular Genetics.

[7]  Silvio C. E. Tosatto,et al.  InterPro in 2017—beyond protein family and domain annotations , 2016, Nucleic Acids Res..

[8]  A. Visel,et al.  Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons , 2016, Neuron.

[9]  J. Seidenberg,et al.  Lung disease caused by ABCA3 mutations , 2016, Thorax.

[10]  J. Whitsett,et al.  Alveolar development and disease. , 2015, American journal of respiratory cell and molecular biology.

[11]  L. Persani,et al.  Novel NKX2-1 Frameshift Mutations in Patients with Atypical Phenotypes of the Brain-Lung-Thyroid Syndrome , 2014, European Thyroid Journal.

[12]  H. Ropers,et al.  Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum , 2014, Journal of Medical Genetics.

[13]  J. Rosenfeld,et al.  Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. , 2013, Chest.

[14]  P. Macchia,et al.  Identification and functional characterization of a novel mutation in the NKX2-1 gene: comparison with the data in the literature. , 2013, Thyroid : official journal of the American Thyroid Association.

[15]  Alan Bridge,et al.  New and continuing developments at PROSITE , 2012, Nucleic Acids Res..

[16]  A. Jobe,et al.  Physiology of transition from intrauterine to extrauterine life. , 2012, Clinics in perinatology.

[17]  M. Vidailhet,et al.  Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  D. Mu,et al.  Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2–1)* , 2012, The Journal of Biological Chemistry.

[19]  L. Guillot,et al.  Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. , 2012, Human molecular genetics.

[20]  T. Volkert,et al.  Genome-Wide Analyses of Nkx2-1 Binding to Transcriptional Target Genes Uncover Novel Regulatory Patterns Conserved in Lung Development and Tumors , 2012, PloS one.

[21]  J. Rello,et al.  Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study , 2011, Critical care.

[22]  R. Epaud,et al.  Interstitial lung diseases in children , 2010, Orphanet journal of rare diseases.

[23]  DelindaA . Johnson,et al.  Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein , 2009, Journal of neurochemistry.

[24]  M. Tomita,et al.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.

[25]  M. Polak,et al.  Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. , 2009, Human molecular genetics.

[26]  J. Whitsett,et al.  Genetic Disorders of Surfactant Dysfunction , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[27]  J. Parma,et al.  Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  J. Pérez-Gil,et al.  Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.

[29]  J. Whitsett,et al.  STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells. , 2008, American journal of respiratory cell and molecular biology.

[30]  S. Anderson,et al.  NKX2.1 specifies cortical interneuron fate by activating Lhx6 , 2008, Development.

[31]  V. Giguère,et al.  Estrogen related receptor-α enhances Surfactant Protein-A gene expression in fetal lung type II cells , 2006 .

[32]  J. Wiener-Kronish,et al.  Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. , 2006, American journal of respiratory cell and molecular biology.

[33]  M. Abramowicz,et al.  Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity. , 2005, Molecular endocrinology.

[34]  M. Polak,et al.  PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. , 2005, The Journal of clinical endocrinology and metabolism.

[35]  M. Yaffe,et al.  TAZ Interacts with TTF-1 and Regulates Expression of Surfactant Protein-C* , 2004, Journal of Biological Chemistry.

[36]  M. Zannini,et al.  The Paired Domain-containing Factor Pax8 and the Homeodomain-containing Factor TTF-1 Directly Interact and Synergistically Activate Transcription* , 2003, The Journal of Biological Chemistry.

[37]  G. Tell,et al.  Redox Effector Factor-1 Regulates the Activity of Thyroid Transcription Factor 1 by Controlling the Redox State of the N Transcriptional Activation Domain* , 2002, The Journal of Biological Chemistry.

[38]  R. Weiss,et al.  Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. , 2002, The Journal of clinical investigation.

[39]  Matthias Mann,et al.  Paraspeckles A Novel Nuclear Domain , 2002, Current Biology.

[40]  F. Askin,et al.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease. , 2001, The New England journal of medicine.

[41]  J. Parma,et al.  Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. , 2001, The Journal of clinical endocrinology and metabolism.

[42]  R. Lauro,et al.  Pax8 has a key role in thyroid cell differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Zammarchi,et al.  Role for p300 in Pax 8 Induction of Thyroperoxidase Gene Expression* , 2000, The Journal of Biological Chemistry.

[44]  P. Minoo,et al.  Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium. , 2000, Biochemical and biophysical research communications.

[45]  J. Whitsett,et al.  Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. , 2000, American journal of respiratory and critical care medicine.

[46]  Ahmed Mansouri,et al.  Follicular cells of the thyroid gland require Pax8 gene function , 1998, Nature Genetics.

[47]  S. Kimura,et al.  Multiple transcripts encoded by the thyroid-specific enhancer-binding protein (T/EBP)/thyroid-specific transcription factor-1 (TTF-1) gene: evidence of autoregulation. , 1998, Endocrinology.

[48]  C. Jones,et al.  Structure of the human Nkx2.1 gene. , 1998, Biochimica et biophysica acta.

[49]  S. Ghaffari,et al.  Diverse effects of anti‐CD44 antibodies on the stromal cell‐mediated support of normal but not leukaemic (CML) haemopoiesis in vitro , 1997, British journal of haematology.

[50]  S. E. Kelly,et al.  Transcription of the Lung-specific Surfactant Protein C Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1996, The Journal of Biological Chemistry.

[51]  M. Arnone,et al.  Mapping and Functional Role of Phosphorylation Sites in the Thyroid Transcription Factor-1 (TTF-1) (*) , 1996, The Journal of Biological Chemistry.

[52]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[53]  J. Whitsett,et al.  Upstream Enhancer Activity in the Human Surfactant Protein B Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1995, The Journal of Biological Chemistry.

[54]  M. Arnone,et al.  The DNA Binding Activity and the Dimerization Ability of the Thyroid Transcription Factor I Are Redox Regulated (*) , 1995, The Journal of Biological Chemistry.

[55]  H. Colten,et al.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.

[56]  R. Lauro,et al.  Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters , 1992, Molecular and cellular biology.

[57]  F. Gonzalez,et al.  thyroid transcription factor TTF-1 . characterization , and structural identity with ( T / EBP ) : cDNA cloning , functional Thyroid-specific enhancer-binding protein , 1991 .

[58]  R. Lauro,et al.  A thyroid‐specific nuclear protein essential for tissue‐specific expression of the thyroglobulin promoter. , 1989, The EMBO journal.